New study shows CT-measured body fat, not BMI, links obesity to higher lung cancer risk via immune T-cell changes—hinting at prevention through weight loss.
|Videos|April 30, 2014
The Utility of Ablative Radiotherapy in Metastatic Breast Cancer
Author(s)Julia White, MD
Julia White, MD, from The Ohio State University Comprehensive Cancer Center, discusses the utility of ablative radiotherapy in metastatic breast cancer.
Advertisement
Clinical Pearls
Julia White, MD, professor, director, Breast Radiation Oncology, vice chair, Clinical Research, The Ohio State University Comprehensive Cancer Center, discusses the utility of ablative radiotherapy in metastatic breast cancer.
- An ablative radiotherapy approach to metastatic regions allows for the avoidance of a surgical procedure.
- Though surgical procedures are typically well tolerated, there are inherent risks associated with anesthesia and complications following surgery.
- Patients must stop systemic therapy in order to undergo surgery. With an ablative radiotherapy approach, there are no treatment interruptions.
Advertisement
Related to this article
Late-breaking ESMO 2026 data show PFS gains with 3 antibody-drug conjugates, a 6-year OS benefit with adjuvant ribociclib, and no OS gain with pembrolizumab.
The phase 2 I-SPY2.2 trial found promising responses with rilvegostomig plus trastuzumab deruxtecan in biomarker-defined, immune-positive tumors.
More than 76% of US counties have no TNBC trial, and only 9.8% of rural counties have one vs 47% of metropolitan counties, a new analysis finds.
At Rutgers Cancer Institute, neuro-oncologists met to discuss the latest trends in precision brain cancer care with FET-PET imaging, advanced molecular testing, and same-day multidisciplinary clinics.
Advertisement
Advertisement
Trending on Targeted Onc
1
ESMO 2026: ADCs and New Combinations Advance Lung Cancer Care
2
Novel ADCs Show Responses in Ovarian and Cervical Cancer at ESMO 2026
3
ESMO 2026: New Data Advance Prostate, Kidney, and Bladder Cancer Care
4
340B Contract Pharmacy Case Rekindles Scrutiny Over Program Intent
5